← Open Payments lookup

GHAZI ASAAD: Open Payments

NPI 1194767681 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,460 in 199 payments from 21 companies in 2025. Trend: 2023 $4,692 · 2024 $4,793 · 2025 $4,460

Food & beverage: $4,460
CompanyPaymentsAmount
ABBVIE INC.56$967
Otsuka America Pharmaceutical, Inc.31$482
Neurocrine BioSciences, Inc.15$453
Teva Pharmaceuticals USA, Inc.15$379
Corium, LLC17$317
Janssen Pharmaceuticals, Inc12$306
Takeda Pharmaceuticals U.S.A., Inc.10$281
Otsuka Pharmaceutical Development & Commercialization, Inc.3$266
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$217
Axsome Therapeutics, Inc.8$204

Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, REXULTI, Azstarys, TRINTELLIX, AUSTEDO XR, CAPLYTA.

Industry payments across CT — which companies pay providers there.